Question special

Because MD-PhD students often complete Step 1 prior to the graduate phase, there will be students with three digit scores who will be evaluated for residency against peers in the Class of 2024 or later with pass/fail scores. Given this reality, around the country, MD-PhD students have concerns about having pass/fail scores for preclinical coursework and lower AOA membership (due to the rigid timing requirements of AOA and less predictable timing of M3 entrance should the G-phase have any delays, as research is wont to do). What might these students (and program directors) do to assuage fears?